Ig Plant Biosciences Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
- Paid Up Capital ₹ 8.89 M
- Company Age 2 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
About Ig Plant Biosciences
Ig Plant Biosciences Private Limited (IPBPL) is a Private Limited Indian Non-Government Company incorporated in India on 02 June 2022 (Two years and eight months 0 days old ). Its registered office is in Navimumbai, Maharashtra.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 8.89 M, as per Ministry of Corporate Affairs (MCA) records.
Sanjay Arora and Tarun Arora serve as directors at the Company.
Company Details
-
LocationNavimumbai, Maharashtra
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U01100MH2022PTC384015
-
Company No.
384015
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
02 Jun 2022
-
Date of AGM
29 Dec 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Ig Plant Biosciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Tarun Arora
|
Director | 02-Jun-2022 | Current |
|
Sanjay Arora
|
Director | 02-Jun-2022 | Current |
Financial Performance of Ig Plant Biosciences.
Enhance accessibility to Ig Plant Biosciences's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ig Plant Biosciences?
Unlock access to Ig Plant Biosciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
I. G. Humi Fresh Private LimitedSanjay Arora is a mutual person
-
Hortifrut Ig Berries Private LimitedSanjay Arora is a mutual person
-
Ig Aatreyas Private LimitedSanjay Arora and Tarun Arora are mutual person
-
I.G.International Private LimitedSanjay Arora and Tarun Arora are mutual person
-
Ig Pears LlpSanjay Arora and Tarun Arora are mutual person
-
Ig Dragon Fruit Llp
Sanjay Arora and Tarun Arora are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ig Plant Biosciences?
Ig Plant Biosciences has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ig Plant Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ig Plant Biosciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.